The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma

BACKGROUND: Whether radiologically detected progressive disease (PD) is an accurate metric for discontinuing sorafenib treatment in patients with hepatocellular carcinoma (HCC) is unclear. We investigated the efficacy of sorafenib treatment after radiologic confirmation of PD in patients with advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Yoshiyuki, Takami, Yuko, Tateishi, Masaki, Ryu, Tomoki, Mikagi, Kazuhiro, Saitsu, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706384/
https://www.ncbi.nlm.nih.gov/pubmed/26745625
http://dx.doi.org/10.1371/journal.pone.0146456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706384/
https://www.ncbi.nlm.nih.gov/pubmed/26745625
http://dx.doi.org/10.1371/journal.pone.0146456

Ejemplares similares